Drupal.behaviors.print = function(context) {window.print();window.close();}>
Meridian Sees 20 to 30 Percent Growth in Fiscal 2012
August 25, 2011
Meridian Sees 20 to 30 Percent Growth in Fiscal 2012
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
FDA Recategorizes Meridian's Molecular Strep A and B Assays as 'Moderate Complexity' Tests
March 19, 2013 / GenomeWeb Daily News
US Diagnostics Business Drives up Meridian Bioscience Q1 Revenues 13 Percent
January 23, 2013 / GenomeWeb Daily News
FDA Clears Meridian's Group A Streptococcus MDx Test
September 17, 2012 / GenomeWeb Daily News
Meridian's Group B Streptococcus Test Approved for Sale in Australia
March 21, 2012 / GenomeWeb Daily News
FDA Clears Meridian Bio's C. difficile Assay
December 28, 2011 / GenomeWeb Daily News